Literature DB >> 8382886

GABAB receptors in the lung.

R W Chapman1, J A Hey, C A Rizzo, D C Bolser.   

Abstract

gamma-Aminobutyric acid (GABA), an important inhibitory neurotransmitter in the mammalian CNS, is also found in peripheral tissues, including the lung. Recent pharmacological studies using selective ligands for GABAA and GABAB receptors demonstrate that of these two, the GABAB receptor is the important receptor subtype controlling lung functions. GABAB agonists inhibit a variety of responses in the airways, including neuronally induced cholinergic- and tachykinin-mediated smooth muscle contraction, microvascular leakage, anaphylactic bronchospasm and cough. Because these conditions are seen in certain respiratory diseases, such as asthma, a selective GABAB agonist may have therapeutic potential for the treatment of this respiratory disorder.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382886     DOI: 10.1016/0165-6147(93)90110-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  18 in total

1.  Different in vitro and in vivo profiles of substituted 3-aminopropylphosphinate and 3-aminopropyl(methyl)phosphinate GABA(B) receptor agonists as inhibitors of transient lower oesophageal sphincter relaxation.

Authors:  A Lehmann; M Antonsson; A Aurell-Holmberg; L A Blackshaw; L Brändén; T Elebring; J Jensen; L Kärrberg; J P Mattsson; K Nilsson; S S Oja; P Saransaari; S von Unge
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Social stress promotes and γ-aminobutyric acid inhibits tumor growth in mouse models of non-small cell lung cancer.

Authors:  Hussein A N Al-Wadei; Howard K Plummer; Mohammad F Ullah; Benjamin Unger; Joel R Brody; Hildegard M Schuller
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-28

3.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

4.  Molecular modelling and conformational analysis of a GABAB antagonist.

Authors:  B Pirard; F Durant
Journal:  J Comput Aided Mol Des       Date:  1996-02       Impact factor: 3.686

5.  Determination of GABA(Aα1) and GABA (B1) receptor subunits expression in tissues of gilts during the late gestation.

Authors:  Zhiyong Fan; Yonghui Chen; Junjun Wang; Jinping Deng; Dexing Hou; Tiejun Li; Lingyuan Yang; Zhonghua Liu; Xiaosong Wu
Journal:  Mol Biol Rep       Date:  2012-10-21       Impact factor: 2.316

6.  Effects of (2R)-(3-amino-2-fluoropropyl)sulphinic acid (AFPSiA) on transient lower oesophageal sphincter relaxation in dogs and mechanism of hypothermic effects in mice.

Authors:  Anders Lehmann; Ann Aurell Holmberg; Ulhas Bhatt; Marianne Bremner-Danielsen; Lena Brändén; Susanne Elg; Thomas Elebring; Kevin Fitzpatrick; William B Geiss; Peter Guzzo; Jorgen Jensen; Gunilla Jerndal; Jan P Mattsson; Karolina Nilsson; Britt-Marie Olsson
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

7.  Differential expression of gamma-aminobutyric acid receptor A (GABA(A)) and effects of homocysteine.

Authors:  Neetu Tyagi; David Lominadze; William Gillespie; Karni S Moshal; Utpal Sen; Dorothea S Rosenberger; Mesia Steed; Suresh C Tyagi
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

8.  GABA-mediated inhibition of the anaphylactic response in the guinea-pig trachea.

Authors:  G Gentilini; S Franchi-Micheli; S Mugnai; D Bindi; L Zilletti
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

9.  Peripheral and central sites of action of GABA-B agonists to inhibit the cough reflex in the cat and guinea pig.

Authors:  D C Bolser; F C DeGennaro; S O'Reilly; R W Chapman; W Kreutner; R W Egan; J A Hey
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

10.  Respiratory effects of baclofen and 3-aminopropylphosphinic acid in guinea-pigs.

Authors:  J A Hey; G Mingo; D C Bolser; W Kreutner; D Krobatsch; R W Chapman
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.